Cerecor Inc (NASDAQ:CERC) Director Armistice Capital, Llc bought 11,218 shares of the company’s stock in a transaction that occurred on Thursday, November 15th. The stock was acquired at an average price of $3.80 per share, for a total transaction of $42,628.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Armistice Capital, Llc also recently made the following trade(s):

  • On Tuesday, November 13th, Armistice Capital, Llc bought 15,287 shares of Cerecor stock. The stock was acquired at an average price of $3.90 per share, for a total transaction of $59,619.30.
  • On Wednesday, October 31st, Armistice Capital, Llc bought 4,586 shares of Cerecor stock. The stock was acquired at an average price of $3.91 per share, for a total transaction of $17,931.26.
  • On Monday, October 29th, Armistice Capital, Llc bought 33,292 shares of Cerecor stock. The stock was acquired at an average price of $3.94 per share, for a total transaction of $131,170.48.
  • On Friday, October 26th, Armistice Capital, Llc purchased 55,899 shares of Cerecor stock. The shares were purchased at an average price of $3.94 per share, for a total transaction of $220,242.06.
  • On Wednesday, October 24th, Armistice Capital, Llc purchased 83,800 shares of Cerecor stock. The shares were purchased at an average price of $4.06 per share, for a total transaction of $340,228.00.
  • On Monday, October 22nd, Armistice Capital, Llc purchased 20,000 shares of Cerecor stock. The shares were purchased at an average price of $4.31 per share, for a total transaction of $86,200.00.
  • On Monday, October 8th, Armistice Capital, Llc purchased 19,588 shares of Cerecor stock. The shares were purchased at an average price of $4.33 per share, for a total transaction of $84,816.04.
  • On Thursday, October 4th, Armistice Capital, Llc purchased 2,015 shares of Cerecor stock. The shares were purchased at an average price of $4.35 per share, for a total transaction of $8,765.25.
  • On Thursday, September 27th, Armistice Capital, Llc purchased 6,473 shares of Cerecor stock. The shares were purchased at an average price of $4.71 per share, for a total transaction of $30,487.83.
  • On Tuesday, September 25th, Armistice Capital, Llc purchased 9,296 shares of Cerecor stock. The shares were purchased at an average price of $4.60 per share, for a total transaction of $42,761.60.

CERC traded down $0.08 on Thursday, reaching $3.77. 49,904 shares of the company traded hands, compared to its average volume of 168,175. Cerecor Inc has a 52-week low of $1.03 and a 52-week high of $5.74. The company has a market capitalization of $162.72 million, a PE ratio of 8.98 and a beta of 1.48. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.54 and a current ratio of 0.62.

Institutional investors and hedge funds have recently made changes to their positions in the stock. BlackRock Inc. grew its position in Cerecor by 630.4% during the second quarter. BlackRock Inc. now owns 27,520 shares of the company’s stock valued at $120,000 after purchasing an additional 23,752 shares in the last quarter. Northern Trust Corp grew its position in Cerecor by 182.0% during the first quarter. Northern Trust Corp now owns 31,506 shares of the company’s stock valued at $135,000 after purchasing an additional 20,333 shares in the last quarter. Cambridge Investment Research Advisors Inc. purchased a new position in Cerecor during the third quarter valued at approximately $169,000. Finally, Spark Investment Management LLC purchased a new position in Cerecor during the second quarter valued at approximately $288,000. 41.69% of the stock is currently owned by hedge funds and other institutional investors.

A number of research firms have recently issued reports on CERC. ValuEngine upgraded shares of Cerecor from a “hold” rating to a “buy” rating in a report on Thursday, August 23rd. TheStreet raised shares of Cerecor from a “d” rating to a “c” rating in a research report on Monday.

ILLEGAL ACTIVITY WARNING: “Insider Buying: Cerecor Inc (CERC) Director Acquires 11,218 Shares of Stock” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2018/11/15/insider-buying-cerecor-inc-cerc-director-acquires-11218-shares-of-stock.html.

About Cerecor

Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation.

See Also: Dividend Aristocrat Index

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.